Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Federal Trade Commission

Generated: September 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for MN-166

  Try a free trial

See Plans and Pricing

« Back to Dashboard

US Patents for MN-166

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
MN-166 ➤ Sign Up Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP) ➤ Sign Up
MN-166 ➤ Sign Up Therapeutic approaches for treating Parkinson's disease Pharnext (Issy les Moulineaux, FR) ➤ Sign Up
MN-166 ➤ Sign Up Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells Selecta Biosciences, Inc. (Watertown, MA) ➤ Sign Up
MN-166 ➤ Sign Up Method of purifying authentic trimeric HIV-1 GP140 envelope glycoproteins comprising a long linker and tag The Catholic University of America (Washington, DC) ➤ Sign Up
MN-166 ➤ Sign Up Ultra-pure agonists of guanylate cyclase C, method of making and using same SYNERGY PHARMACEUTICALS, INC. (New York, NY) ➤ Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for MN-166

Drugname Country Document Number Estimated Expiration Related US Patent
MN-166 Canada 2961033 2034-09-11 ➤ Sign Up
MN-166 European Patent Office 3192791 2034-09-11 ➤ Sign Up
MN-166 Japan WO2016039408 2034-09-11 ➤ Sign Up
MN-166 World Intellectual Property Organization (WIPO) 2016039408 2034-09-11 ➤ Sign Up
MN-166 Australia 2012222348 2031-03-01 ➤ Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.